<!doctype html><html><title>Booster Timeline</title><meta name=viewport content="width=device-width,initial-scale=1"><link rel=stylesheet href=/css/style.css><link rel=stylesheet href=/css/media.css><body><div class=content><div class="container m-auto"><div class="w-md-55 m-auto mt-2 text-center"><a class="title text-black text-decoration-none" href=/>Booster Timeline</a></div></div><div class="container content m-auto"><div id=article class="w-md-55 m-auto"><div class="mt-1 article-title text-capitalize-letter">Tweets by Eric Topol</div><div class="mt-2 italic post-date">Aug 4, 2021</div><div class="mt-2 article"><div><div class=thread><div class=thread-content>Link to the preprint<p><a href=https://t.co/HihmmLKOvn>https://t.co/HihmmLKOvn</a></p><p>Extensive PCR testing showed that fully vaccinated people had lower viral loads than un- or partially vaccinated, supporting decreased potential for Delta transmission</div></p><hr><div class=profile><a href=https://twitter.com/erictopol/status/1422921366131515398 target=_blank rel=noreferer>07:04 UCT-7</a></div><div class=content>The most rigorous assessment to date for Delta breakthroughs, w/ random sampling. The previous @PHE_uk estimate for vaccine effectiveness vs Delta was 88% for Pfizer, 60% for AZ. Israel's (Pfizer) was 60%, likely accurate. No wonder why we're seeing the increase in breakthroughs</div><a href=/twitter/erictopol/images/E7857_iVcAAejPH.png><img src=/twitter/erictopol/images/E7857_iVcAAejPH.png alt="Twitter image"></img></a></div><div class=thread><div class=thread-content>The FDA full approval of vaccines in now expected by Labor Day; it took months to get transparency and communication w/ the public<p><a href=https://www.washingtonpost.com/health/2021/08/02/coronavirus-vaccines-fda-full-approval-timeline/ target=_blank rel=noreferer><a href=https://www.washingtonpost.com/health/2021/08/02/c>https://www.washingtonpost.com/health/2021/08/02/c</a> &mldr;</a></p><p>This Q&A shows the prior lack of understanding of its urgency; also the implications on boosters</div><a href=/twitter/erictopol/images/E78-_N4UYAc1hso.jpg><img src=/twitter/erictopol/images/E78-_N4UYAc1hso.jpg alt="Twitter image"></img></a><hr><div class=profile><a href=https://twitter.com/erictopol/status/1422944272383283203 target=_blank rel=noreferer>08:35 UCT-7</a></p></div><div class=content>Labor Day target (more likely end August)<p><a href=https://www.nytimes.com/live/2021/08/04/world/covid-delta-variant-vaccine#the-fda-could-grant-full-approval-to-pfizers-vaccine-by-early-september target=_blank rel=noreferer><a href=https://www.nytimes.com/live/2021/08/04/world/covi>https://www.nytimes.com/live/2021/08/04/world/covi</a> &mldr;</a>
by @SharonLNYT @noahweiland</p><p><a href=https://www.nytimes.com/2021/07/01/opinion/fda-vaccines-full-approval.html target=_blank rel=noreferer><a href=https://www.nytimes.com/2021/07/01/opinion/fda-vac>https://www.nytimes.com/2021/07/01/opinion/fda-vac</a> &mldr;</a>
@nytopinion</p><p>I applaud the transparency, making it #1 priority.</p><p>It&rsquo;s a shame this wasn&rsquo;t the policy months ago, pre-Delta, when it would have had huge impact</div><a href=/twitter/erictopol/images/E79PU2wUUAMZwuV.jpg><img src=/twitter/erictopol/images/E79PU2wUUAMZwuV.jpg alt="Twitter image"></img></a><a href=/twitter/erictopol/images/E79PWZdVIAEGXdf.jpg><img src=/twitter/erictopol/images/E79PWZdVIAEGXdf.jpg alt="Twitter image"></img></a></div></p><div class=thread><div class=thread-content>Summary Delta breakthrough studies, Ct/viral load, vaccine effectiveness (VE)<p>Only 1 large study of Ct/viral load, shows some vaccine reduction</p><p>VE ranges 39-88%; it&rsquo;s likely ‚â§ 60% at best for mRNA</p><p>More data needed, but points to need for boosters for at least some people</div><a href=/twitter/erictopol/images/E79d4qJUYAIwtQZ.jpg><img src=/twitter/erictopol/images/E79d4qJUYAIwtQZ.jpg alt="Twitter image"></img></a><hr><div class=thread-content>Overall, these findings certainly are concordant w/ increased Delta breakthrough symptomatic infections we&rsquo;re seeing and a major decline in protection (~95% w/ mRNA) compared with previous strains, as reviewed here <a href=https://t.co/al1vE7goSn>https://t.co/al1vE7goSn</a></div></p><hr><div class=thread-content>Recall that 1-dose mRNA or AZ had little (30%) efficacy (1st study in Table). All of this reflects Delta's immune evasiveness. We're very lucky it's holding up for reduction of hospitalizations/deaths but thisü¶†is far more formidable for both transmission and our immune response</div><hr><div class=profile><a href=https://twitter.com/erictopol/status/1422992503259549696 target=_blank rel=noreferer>11:47 UCT-7</a></div><div class=content>Other implications for the VE drop vs infections.<p>For awhile we wondered if the mRNA dosing schedule is Israel (3 weeks) vs UK (8-12 weeks) could account for 39-60% vs 88%, respectively. The new UK study doesn&rsquo;t break down vaccine %, but makes this explanation less likely</div></p></div><div class=thread><div class=thread-content>There's little good news for the US Delta wave, but we may be seeing the peak case growth rate for the top 2 states, Louisiana and Florida</div><a href=/twitter/erictopol/images/E795ZpGVkAIupGj.jpg><img src=/twitter/erictopol/images/E795ZpGVkAIupGj.jpg alt="Twitter image"></img></a><hr><div class=profile><a href=https://twitter.com/erictopol/status/1422993905495134213 target=_blank rel=noreferer>11:52 UCT-7</a></div><div class=content>A better way to see the slowing of case growth is via the log plot, and it looks pretty consistent across the top states</div><a href=/twitter/erictopol/images/E799MOGUcAIHX6K.jpg><img src=/twitter/erictopol/images/E799MOGUcAIHX6K.jpg alt="Twitter image"></img></a></div><div class=tweet><div class=profile><a href=https://twitter.com/erictopol/status/1423028440664403968 target=_blank rel=noreferer>14:09 UCT-7</a></div><div class=content>In the pandemic, immunocompromised people (~3% of Americans) are not getting adequate recognition for the potential of in-host evolution of the virus (highlighted studies) and the need for far better approaches to protect them <a href="https://www.nejm.org/doi/full/10.1056/NEJMsb2104756?query=featured_home" target=_blank rel=noreferer>https://www.nejm.org/doi/full/10.1056/NEJMsb210475 ...</a>
@NEJM</div><a href=/twitter/erictopol/images/E7-VPMrVcAAvJ40.jpg><img src=/twitter/erictopol/images/E7-VPMrVcAAvJ40.jpg alt="Twitter image"></img></a></div><div class=thread><div class=thread-content>Just published @NEJM<p>Prevention of Covid for household contacts with exposure via a single subcutaneous injection: results of a randomized trial of combination monoclonal antibodies shows marked benefit</p><p><a href=http://www.nejm.org/doi/full/10.1056/NEJMoa2109682 target=_blank rel=noreferer><a href=http://www.nejm.org/doi/full/10.1056/NEJMoa2109682>http://www.nejm.org/doi/full/10.1056/NEJMoa2109682</a></a></p></div><a href=/twitter/erictopol/images/E7-UV4IVgAEYNkV.jpg><img src=/twitter/erictopol/images/E7-UV4IVgAEYNkV.jpg alt="Twitter image"></img></a><a href=/twitter/erictopol/images/E7-UXvhUUAM7eGc.jpg><img src=/twitter/erictopol/images/E7-UXvhUUAM7eGc.jpg alt="Twitter image"></img></a><hr><div class=thread-content>fixed link<p><a href=https://t.co/WT8oPg65EH>https://t.co/WT8oPg65EH</a></div></p><hr><div class=profile><a href=https://twitter.com/erictopol/status/1423035331327119360 target=_blank rel=noreferer>14:37 UCT-7</a></div><div class=content>This is a 1st in 2 ways<ol><li><p>Use of a sub-Q (under the skin) injection rather than an intravenous infusion of the antibodies; the requirement for an IV infusion had led to reduced use for treatment</p></li><li><p><em>Preventing</em> covid after exposure üëç</div></p></li></ol></div><div class=tweet><div class=profile><a href=https://twitter.com/erictopol/status/1423039487156707331 target=_blank rel=noreferer>14:53 UCT-7</a></div><div class=content>Notable: several countries with Delta waves had abrupt U-turns that were short-lived or are stuttering<p>@OurWorldInData</div><a href=/twitter/erictopol/images/E7-mclEVEAAK1jw.jpg><img src=/twitter/erictopol/images/E7-mclEVEAAK1jw.jpg alt="Twitter image"></img></a></div></p><div class=tweet><div class=profile><a href=https://twitter.com/erictopol/status/1423051289429086208 target=_blank rel=noreferer>15:40 UCT-7</a></div><div class=content>During the 3rd wave in the USA, cases got above 300,000 per day and deaths above 4,000.<p>In the 4th, Delta wave, cases have already reached ~150,000 in a day, with deaths ~400 (7-day avg)</p><p>[and yes, there&rsquo;s a lag; hospitalizations and #LongCovid are a big deal in this wave]</div></p></div><div class=tweet><div class=profile><a href=https://twitter.com/erictopol/status/1423098035408564225 target=_blank rel=noreferer>18:46 UCT-7</a></div><div class=content>There really are 2 lines, not 1, for the US and Israel 4th wave ascents.<p>Israel is quickly getting people age >60 with booster shots, 11% in 3 days; it&rsquo;ll be important to watch for impact in the weeks ahead</p><p><a href=https://twitter.com/erlichya/status/1422785542329151490 target=_blank rel=noreferer><a href=https://twitter.com/erlichya/status/14227855423291>https://twitter.com/erlichya/status/14227855423291</a> &mldr;</a></p></div><a href=/twitter/erictopol/images/E7_bAouVEAI2J0k.jpg><img src=/twitter/erictopol/images/E7_bAouVEAI2J0k.jpg alt="Twitter image"></img></a></div><div class=tweet><div class=profile><a href=https://twitter.com/erictopol/status/1423117888991367168 target=_blank rel=noreferer>20:05 UCT-7</a></div><div class=content>The @Newsweek magazine must be getting desperate for sales to go with this cover. Delta is bad enough; there's no clinical evidence that Delta "Plus" or Lambda provide competition with it. Let's not make bad matters worse and beat this *&^%'inü¶†</div><a href=/twitter/erictopol/images/E7_qEZjVgAIcGwC.jpg><img src=/twitter/erictopol/images/E7_qEZjVgAIcGwC.jpg alt="Twitter image"></img></a></div></div></div><div class=mt-2></div><div class="mt-4 w-md-80 border-top text-default"><div class="d-md-flex d-flex-space-between"><div class="w-md-40 pt-2"><div class="mb-2 text-medium"><a href=https://science-democracy.github.io/twitter/erictopol/08/03/>Previous</a></div></div><div class="w-md-40-max pt-2"><div class="mb-2 text-medium"><a href=https://science-democracy.github.io/twitter/erictopol/08/05/>Next</a></div></div></div></div></div></div></div><div class="container m-auto"><div class="d-flex d-flex-space-between"><div class=mt-4></div></div></div></body></html>